Open the map

United TherapeuticsUTHR

Biotech & innovation · NASDAQ · USA

$532.78
Down 2.2% todayClose

Up 11.9% this year but −1.8% since June 26, behind the life science sector at +10.7%. United Therapeutics supplies 2 mapped companies and buys from 1.

Market cap
$23.4B
This year
+11.9%
1 year
+19.3%
P/E
17.8
P/S
7.4
P/B
3.7

Price vs the life science sector

since Jun 26UTHRLife science sector, equal weight
United Therapeutics (UTHR) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. UTHR: −1.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8UTHR −1.8%Sector +10.7% United Therapeutics (UTHR) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. UTHR: −1.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8UTHR−1.8%Sector+10.7%

Supply chain

1 supplier · 2 customers
SUPPLIERS →→ CUSTOMERSIQVIA Holdings (IQV)IQVIQVIA Holdings+0.3%The Cigna Group (CI)CIThe Cigna Group+0.9%CVS Health (CVS)CVSCVS Health−0.2%UTHRUnited Therapeu…

Suppliers 1

Customers 2

Open the full chain →

About United Therapeutics

Pulmonary hypertension accounts for the marketed drugs, Tyvaso, Remodulin and Orenitram among them. A separate programme works on organs for transplant, including xenotransplantation.

Theme exposure

Pulmonary hypertensionOrgan manufacturingRare diseases

Products

  • PAH treatments (Tyvaso)
  • Remodulin & Orenitram
  • Organ & transplant technology

Competitors

Risks

  • PAH competition
  • Pipeline execution

Same segment: Biotech & innovation

Innovation-driven biotech companies focused on novel treatment modalities. Segment 3 of 8 in the Medicine, pharma & life science value chain.

AmgenAMGN−1.4%Gilead SciencesGILD+0.2%Vertex PharmaceuticalsVRTX−0.5%ModernaMRNA+0.3%RegeneronREGN−0.3%BiogenBIIB−1.7%Alnylam PharmaceuticalsALNY+0.1%IncyteINCY−0.6%

Compare UTHR

Side by side with the largest companies in the same segment.

UTHR vs AMGNUTHR vs GILDUTHR vs VRTXUTHR vs MRNAUTHR vs REGNUTHR vs BIIB

See where United Therapeutics sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →